ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2026
Heparin Resistance - A Reality or Fallacy.
Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The term heparin resistance is often used by clinicians, despite the lack of specific criteria. Defining true heparin resistance remains problematic in both adults and pediatrics, as there is no consensus on a "maximum" heparin dose. Furthermore, the indication or setting of heparin use may impact perceptions of what is considered a maximum dose. For example, what might be considered a normal dose in the setting of cardiac surgery might be considered "high" in the intensive care unit. There is also a mixed opinion as to the ideal monitoring strategy. Given the lack of a standardized definition and the misunderstandings that exist surrounding the topic of heparin resistance, this review serves to provide insights into heparin resistance in pediatric patients and potential management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.